Application approval list

No.

Name

Institution

Project Name

Patient No.

Approval date

20001

Tsai, Jih-Jin

Tropical Medicine Center, Kaohsiung Medical University Chung-Ho Memorial Hospital

Research and development of COVID-19 precision diagnostics

30

20200422

20002

Guan-Da Syu

Department of Biotechnology and Bioindustry Sciences, National Cheng Kung University

Antibody Profiling of COVID-19 Using Coronavirus Protein and Peptide Microarray

110

20201028

20003

Liang-Tzung Lin

Microbiology and Immunology, Taipei Medical University

Establishment of SARS-CoV-2 Pseudoparticle System as Diagnostic and Therapeutic Testing Platform

10

20200714

20004

Tan Tse-Hua

Immunology Research Center, National Healthy Research Institutes

Signaling Pathways as Therapeutic Targets for COVID-19 infection

60

20201028

20005

Chang-Wei Li

AllBio Science, Inc

The COVID-19 rapid test development

35

20200610

20007

Yen-Hsu Chen

Medical School, Kaohsiung Medical University

Development of a rapid diagnosis CMOS of 2019-nCoV

55

20200714

20008

Hsiang-Tsui Wang

Department of Pharmacology, National Yang-Ming University

Using nano-imaging approaches to reveal the interplay of SARS-CoV-2 spike protein with cellular receptors and SARS-CoV-2 spike protein-induced cellular responses

90

20201230

20009

Hung-Wei Yang

Institute of Medical Science and Technology, National Sun Yat-sen University

A ultrasensitive EasyVial for rapid diagnostic test of viral infections

90

20200714

20010

Chang-Wei Li

AllBio Science, Inc

The COVID-19 rapid test development

80

20200714

20011

Lung-Wen Tai

R&D Division, Agnitio Science & Technology, Inc.

BioIC SARS-CoV2 IgG/IgM Detection Kit-Performance Evaluation

100

20200921

20012

Ming-Yu Lin

Department of Biosensing Development, Helios Bioelectronics Inc.

Detection of protein from COVID-19 serum samples by semiconductor-based biosensors

10

20200812

20013

Jia-Chuan Hsu

Section of Biologics, Division of Research and Analysis, Taiwan Food and Drug Administration, Ministry of Health and Welfare

Preparation of SARS-CoV-2 antibodies for COVID-19 vaccine candidates evaluation

40

20200812

20014

Evelyn Chen

BioMedical Sensing Business Division, DELBIO, INC.

COVID-19 IgG/IgM Rapid Test Clinical Trials

180

20200921

20015

Pei-Min Chen

Pre-clinical and clinical study Dept. United Biomedical, Inc., Asia

Analysis of immunogenicity in COVID-19 convalescent serum samples

30

20200921

20016

Shu-chen Kuo

National Institutes of infectious Diseases and Vaccinology, National Healthy Research Institutes

Antibody responses to SARS-CoV-2 in patients with COVID-19

20

20200921

20017

Jia-Chuan Hsu

Section of Biologics, Division of Research and Analysis, Taiwan Food and Drug Administration, Ministry of Health and Welfare

Preparation of SARS-CoV-2 antibodies for COVID-19 vaccine candidates evaluation

55

20201028

20018

Shih-Jen Liu

National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes

Development of quantitative rapid test for Covid-19 disease

70

20201119

20019

Der-Yuan Chen

Division of Rheumatology and Immunology, China Medical University Hospital

The associations of hyperferritinemia with disease pathogenesis and COVID-19 infection in rheumatic patients

30

20201119

20020

Ching-Wei Tsai

Department of Biosensing Development, Helios Bioelectronics Inc.

Detection of protein from COVID-19 serum samples by semiconductor-based biosensors

105

20201119

20021

Yahui Huang

Division of Human Pharmaceuticals and Diagnostics, Schweitzer Biotech Company Ltd.

Cross Reactivity Study of SBC COVID-19 IgG ELISA Kit

80

20201230

21022

Jia-Chuan Hsu

Section of Biologics, Division of Research and Analysis, Taiwan Food and Drug Administration, Ministry of Health and Welfare

Preparation of SARS-CoV-2 antibodies for COVID-19 vaccine candidates evaluation

67

20210222

21023

Tzou Yien Lin

Department of Pediatrics, Chang Gung Memorial Hospital

A haemagglutination test for rapid detection of antibodies to SARS-CoV-2

100

20210421

21024

Guann-Yi Yu

National Institute of Infectious Diseases and Vaccinology, National Health Research Institutes

RNA viral infection and pathogenesis

35

20210421

21025

Guan-Da Syu

Department of Biotechnology and Bioindustry Sciences, National Cheng Kung University

Antibody Profiling of COVID-19 Using Coronavirus Protein and Peptide Microarray

60

20210625

21026

Hsiang-Ju Chen

Molecular Virology, LumiSTAR Biotechnology, Inc.

Development of rapid SARS-CoV-2 Neutralizing Antibody Serologic Detection Kit

160

20210625

21027

Kent Yeh

Product development department, Avirovac

SARS-CoV-2 Neutralization Antibody ELISA Development

60

20210625

21028

Der-Yuan Chen

Division of Rheumatology and Immunology, China Medical University Hospital

The association of anti-cytokine antibodies with disease activity parameters and infection in rheumatic patients

120

20210820

21029

Hsin-Chou Yang

Institute of Statistical Science, Academia Sinica

Establishing NGS analytical model for understanding the infectious program of SARS-CoV-2

200

20211007

21030

Yahui Huang

Division of Human Pharmaceuticals and Diagnostics

Clinical Agreement Study of SBC COVID-19 ELISA

80

20211007

21031

Tsai, Jih-Jin

Tropical Medicine Center, Kaohsiung Medical University Chung-Ho Memorial Hospital

Research and development of COVID-19 precision diagnostics

120

20211217

21032

Tsai-Ling Liao

Department of Medical Research, Taichung Veterans General Hospital

The pathogenic role of extracellular vesicles and cellular factors in COVID-19

20

20220223

22033

Chun Liang Shih

Panion & BF Biotech inc.

Evaluation of the detection performance of Vstrip COVID-19 S-RBD Antibody Rapid Test for sera of patients infected with COVID-19 variant strains

18

20220421

22034

Chao-Lun Lai

Department of Internal Medicine, National Taiwan University Hospital Hsin-Chu Branch

Comparison of neutralizing antibody levels against SARS-CoV-2 variants before and after the third SARS-CoV-2 booster shot

55

20220617

22035

Shih-Hsien Hsu

Graduate Institute of Medicine, Kaohsiung Medical University

ISX-induced hepatic steatosis impacts the progression of COVID-19

100

20220831

22036

Hsiang-Tsui Wang

Department of Pharmacology, National Yang Ming Chiao Tung University

Using nano-imaging approaches to reveal the interplay of SARS-CoV-2 spike protein with cellular receptors and SARS-CoV-2 spike proteininduced cellular responses.

250

20221024

22037

Yu-Li Liu

Center for Neuropsychiatric Research, National Health Research Institutes

Preliminary study on the correlation between brain nerve damage and biomarkers for disease symptoms in patients with COVID

200

20230104

23038

Hu Ching-Wen

Nursing department, Tung’s Taichung MetroHarbor Hospital

Clinical characteristics of mild COVID-19 with DM patients in Taiwan

250

20230222

23039

Shih-Cheng Chen

National Institute Cancer Research, National Health Research Institutes

Validation of genetic variations associated to severe Covid-19 from NBCT data

250

20230419

23040

Yu-Li Liu

Center for Neuropsychiatric Research, National Health Research Institutes

Preliminary study on the correlation between brain nerve damage and biomarkers for disease symptoms in patients with COVID

200

20230420

23041

Yu-Li Liu

Center for Neuropsychiatric Research, National Health Research Institutes

Preliminary study on the correlation between brain nerve damage and biomarkers for disease symptoms in patients with COVID

200

20231213

23042

Yu-Li Liu

Center for Neuropsychiatric Research, National Health Research Institutes

Preliminary study on the correlation between brain nerve damage and biomarkers for disease symptoms in patients with COVID

250

20231213

24043

Guan-Da Syu

Department of Biotechnology and Bioindustry Sciences, National Cheng Kung University

Antibody Profiling of COVID-19 Using Coronavirus Protein and Peptide Microarray

60

20240227

Comments are closed.